Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: Evidence from the Caerphilly and Speedwell cohort

Thrombosis and Haemostasis

Volumn 87, Issue 3, 2002, Pages 421-425

  Baker, Ian A ^a   Pickering, Janet ^a   Elwood, Peter C ^a   Bayer, Antony ^a   Ebrahim, Shah ^a  

^a Avon Health Authority   (United Kingdom)

Author keywords

Fibrinogen; Ischaemic heart disease; Plasma viscosity; Stroke; White blood cell count

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PLASMA VISCOSITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; BLOOD VISCOSITY; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; STATISTICAL MODEL;

BLOOD VISCOSITY; CEREBRAL INFARCTION; COHORT STUDIES; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 0036121754     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613020     Document Type: Article

References (29)

1. Plasma fibrinogen - A major coronary risk factor
2. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischaemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies
3. Fibrinolytic activity, clotting factors and long term incidence of ischaemic heart disease in the Northwick Park Study
4. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. The Caerphilly and Speedwell Studies
5. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women: Scottish Heart Health Study
6. Fibrinogen as a risk factor for stroke and myocardial infarction
7. Fibrinogen and risk of cardiovascular disease: The Framingham Study
8. Hemostatic factors as predictors of ischaemic heart disease and stroke in the Edinburgh Artery Study
9. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants
10. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: Results from the cardiovascular health study
11. The leukocyte count as a predictor of myocardial infarction
12. White blood cell count and cardiovascular disease. Insights from the Framingham Study
13. Total and differential leukocyte counts as predictors of ischemic heart disease: The Caerphilly and Speedwell studies
14. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease
15. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
16. The Caerphilly and Speedwell collaborative heart disease studies
17. The Caerphilly and Speedwell Stroke study: I: Methods and incident events
18. A new red-sensitive micro-nephelometer
19. The viscosity of human blood plasma: Its measurement in health and disease
20. Relation of Helicobacter pylori infection to 13-year mortality and incidence of ischaemic heart disease in the Caerphilly prospective heart disease study
21. Measuring plasma fibrinogen to predict stroke and myocardial infarction
22. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction - The PRIME Study. Prospective epidemiological study of myocardial infarction
23. Prospective study markers of haemostatic function with risk of ischaemic stroke
24. Haematocrit, viscosity, erythrocyte sedimentation rate: Meta-analysis of prospective studies of coronary heart disease
25. Total and differential leucocyte counts as predictors of ischaemic heart disease: The Caerphilly and Speedwell Studies
26. Smoking and leucocyte-counts. Results of an epidemiological survey
27. Leucocyte counts and risk of major coronary heart disease events
28. White cell count and stroke incidence and death. The NHANES I epidemiologic follow-up study
29. Gene-environment interaction in the determination of levels of plasma fibrinogen